Movement disorders related to antidiabetic medications: a real-world pharmacovigilance study.
與抗糖尿病藥物相關的運動障礙:一項真實世界的藥物監測研究。
Prog Neuropsychopharmacol Biol Psychiatry 2024-08-25
Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study.
評估2012年至2017年間美國食品藥物管理局批准的抗糖尿病藥物不良藥物反應報告:一項藥物警戒研究。
Ther Adv Drug Saf 2023-06-20
Do oral antidiabetic medications alter the risk of Parkinson's disease? An updated systematic review and meta-analysis.
口服抗糖尿病藥物是否改變帕金森氏症的風險?一項更新的系統性回顧和荟萃分析。
Neurol Sci 2023-11-22
Exploring the Potential of Antidiabetic Agents as Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: A Comprehensive Review.
探索抗糖尿病藥物作為治療阿茲海默症和帕金森病的潛力:全面回顧。
Cureus 2023-10-18
Repurposing and clinical attributes of antidiabetic drugs for the treatment of neurodegenerative disorders.
抗糖尿病藥物在治療神經退行性疾病中的再利用和臨床特性。
Eur J Pharmacol 2023-12-16
Meta-analysis of Association between Newer Glucose-Lowering Drugs and Risk of Parkinson's Disease.
新型降糖藥物與帕金森氏症風險之間的關聯的荟萃分析。
Mov Disord Clin Pract 2024-02-10
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease in Patients with Type 2 Diabetes: A Population-Based Cohort Study.
GLP-1 受體激動劑與 2 型糖尿病患者帕金森病風險:一項基於人群的隊列研究。
Mov Disord 2024-08-27
A comprehensive assessment of the association between common drugs and psychiatric disorders using Mendelian randomization and real-world pharmacovigilance database.
使用孟德爾隨機化和實際世界藥物監測數據庫對常見藥物與精神疾病之間的關聯進行全面評估。
EBioMedicine 2024-08-27
Sodium-glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real-world patients with type 2 diabetes.
鈉-葡萄糖共轉運蛋白 2 抑制劑與實際世界中 2 型糖尿病患者罹患帕金森病的風險。
Diabetes Obes Metab 2024-09-11
Anti-diabetic drug use and reduced risk of Parkinson's disease: A community-based cohort study.
抗糖尿病藥物使用與帕金森病風險降低:一項社區基礎的隊列研究。
Parkinsonism Relat Disord 2024-09-11
SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes.
SGLT2 抑制劑使用與 2 型糖尿病患者罹患癡呆症和帕金森病的風險。
Neurology 2024-09-18